Posted in Web HAGENS BERMAN, NATIONAL TRIAL ATTOREYS, Encourages Novavax December 8, 2021 Novavax, Inc. (NVAX) Securities Fraud Class Action: The lawsuit alleges that Defendants misrepresented Novavax’s progress toward successfully developing its COVID-19 vaccine (NVX-CoV2373 … https://www.globenewswire.com/news-release/2021/11/16/2334903/32716/en/HAGENS-BERMAN-NATIONAL-TRIAL-ATTOREYS-Encourages-Novavax-NVAX-Investors-with-Significant-Losses-to-Contact-Firm-s-Attorneys-Now-Securities-Class-Action-Filed.html